突肉瘤:临床病理变量对英国人口总生存时间的影响
Bill Robertson-Smith1, Jackie Campbell2, Karen Anthony3
1Trauma and Orthopaedics, University Hospitals of Northamptonshire, University of Northampton, East Midlands Sarcoma Service, UK.
Surgical oncology
|March 20, 2025
概括
辅助放射疗法改善了突肉瘤患者的生存率. 这项研究发现,除了瘤大小和位置外,它也是一个重要的预后标志物,影响了整体生存率.
科学领域:
- 在瘤学瘤学.
- 手术病理学手术病理学
- 放射疗法是一种放射治疗.
背景情况:
- 突肉瘤占恶性软组织瘤的5-10%.
- 治疗通常包括手术,放射治疗和/或化疗.
- 对于突肉瘤,目前还没有确定的治疗方案.
研究的目的:
- 为了描述英国地区的突肉瘤患者群体.
- 为了确定影响整体生存的临床病理变量.
主要方法:
- 来自东米德兰兹癌症服务数据库的94名突肉瘤患者的分析.
- 临床病理学变量的提取.
- 卡普兰-梅尔和考克斯回归分析用于生存预测.
主要成果:
- 诊断时的平均年龄为42岁,53%的人患有下肢瘤.
- 增加瘤大小和远期复发对生存率产生了负面影响 (p<0.0001).
- 手术和放射治疗显著改善了整体存活率 (p=0.02).
结论:
- 辅助放射治疗是一种新的,独立的预后标志物,用于突肉瘤.
- 瘤的大小和位置是显著的生存预测指标.
- 对最佳治疗策略的进一步研究是有必要的.
相关概念视频
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Comparing the Survival Analysis of Two or More Groups
110
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
110
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Assumptions of Survival Analysis
77
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
77


